CN111848776B - 聚乙二醇修饰的rhBNP及其制备方法 - Google Patents
聚乙二醇修饰的rhBNP及其制备方法 Download PDFInfo
- Publication number
- CN111848776B CN111848776B CN202010899033.XA CN202010899033A CN111848776B CN 111848776 B CN111848776 B CN 111848776B CN 202010899033 A CN202010899033 A CN 202010899033A CN 111848776 B CN111848776 B CN 111848776B
- Authority
- CN
- China
- Prior art keywords
- rhbnp
- modified
- buffer solution
- polyethylene glycol
- elution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (18)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010899033.XA CN111848776B (zh) | 2020-08-31 | 2020-08-31 | 聚乙二醇修饰的rhBNP及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010899033.XA CN111848776B (zh) | 2020-08-31 | 2020-08-31 | 聚乙二醇修饰的rhBNP及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111848776A CN111848776A (zh) | 2020-10-30 |
CN111848776B true CN111848776B (zh) | 2022-03-18 |
Family
ID=72967624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010899033.XA Active CN111848776B (zh) | 2020-08-31 | 2020-08-31 | 聚乙二醇修饰的rhBNP及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111848776B (zh) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7648962B2 (en) * | 2002-11-26 | 2010-01-19 | Biocon Limited | Natriuretic compounds, conjugates, and uses thereof |
SG159387A1 (en) * | 2002-11-26 | 2010-03-30 | Biocon Ltd In | Modified natriuretic compounds, conjugates, and uses thereof |
TW200502251A (en) * | 2003-11-26 | 2005-01-16 | Nobex Corp | Natriuretic compound conjugates, conjugates, and uses thereof |
WO2006076471A2 (en) * | 2005-01-12 | 2006-07-20 | Nobex Corporation | Bnp conjugates and methods of use |
CL2008003476A1 (es) * | 2007-11-21 | 2009-08-14 | Biomarin Pharm Inc | Variante del peptido natriuretico de tipo c (cnp); composicion farmaceutica que la comprende; y su uso para tratar una displasia del esqueleto o un trastorno de la musculatura lisa vascular. |
US20110206633A1 (en) * | 2008-09-19 | 2011-08-25 | Nektar Therapectics | Polymer conjugates of cd-np peptides |
-
2020
- 2020-08-31 CN CN202010899033.XA patent/CN111848776B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN111848776A (zh) | 2020-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100593143B1 (ko) | 에리트로포이에틴 컨쥬게이트 | |
EP1404178B1 (en) | Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same | |
RU2498814C2 (ru) | Пэг-модифицированный эксендин или аналог эксендина и его композиции и применение | |
CN101405019B (zh) | 一种治疗肿瘤的药物及其应用 | |
WO2010065439A1 (en) | Variants of fibroblast growth factor 21 | |
JP2008540565A (ja) | Glp−1peg化化合物 | |
AU6429900A (en) | Erythropoietin derivatives | |
KR100694994B1 (ko) | 사람 과립구 콜로니 형성인자 동종체 | |
EP4159750A1 (en) | Dual-agonist compound for both glp-1 and gip receptors and application thereof | |
JP5458416B2 (ja) | 二本鎖ポリエチレングリコール化成長ホルモン、その製造方法およびその使用 | |
EP3439702B1 (en) | Conjugated c1 esterase inhibitor and uses thereof | |
CN111848776B (zh) | 聚乙二醇修饰的rhBNP及其制备方法 | |
EP2691119B1 (en) | Pharmaceutical preparation | |
WO2009079911A1 (fr) | Conjugué d'érythropoïétine pégylée et procédé de préparation et utilisations | |
TW200944236A (en) | G-CSF conjugates modified by water-soluble polymers | |
CN114539384A (zh) | 聚乙二醇化长效生长激素及其制备方法和医药应用 | |
KR101417934B1 (ko) | 비펩타이드성 중합체-인슐린 다량체 및 이의 제조방법 | |
US20220033454A1 (en) | Interleukin-22 fusion proteins, and their pharmaceutical compositions and therapeutic applications | |
CN111978390B (zh) | 聚乙二醇修饰的rhBNP及其用途 | |
KR101104574B1 (ko) | 폴리에틸렌글리콜로 화학적으로 수식된 인간 성장 호르몬, 이의 제조방법 및 용도 | |
CN101381412B (zh) | 聚合物/重组人促红素偶联物 | |
CN114920819A (zh) | 重组人生长激素突变体、其聚乙二醇衍生物、聚乙二醇衍生物的制备方法及其药物用途 | |
CN116135973A (zh) | 低糖基化修饰的激肽原酶及其聚乙二醇修饰物和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 230088 China (Anhui) pilot Free Trade Zone, Hefei, Anhui Province a11-1, 13 / F, block a, building J1, phase II, innovation industrial park, No. 2800, innovation Avenue, high tech Zone, Hefei Patentee after: Jingze biomedical (Hefei) Co.,Ltd. Patentee after: SHANGHAI JINGZE BIOLOGICAL TECHNOLOGY CO.,LTD. Patentee after: Chengdu Jingze biopharmaceutical Co.,Ltd. Address before: 226100 B6 / F, No.100 Dongtinghu Road, Linjiang Town, Haimen City, Nantong City, Jiangsu Province Patentee before: Jiangsu Jingze Biomedical Co.,Ltd. Patentee before: SHANGHAI JINGZE BIOLOGICAL TECHNOLOGY CO.,LTD. Patentee before: Chengdu Jingze biopharmaceutical Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: A11-1, 13/F, Block A, Building J1, Phase II, Innovation Industrial Park, No. 2800, Innovation Avenue, High-tech Zone, Hefei, Anhui Province, 230088 Patentee after: Jingze Biomedical (Hefei) Co.,Ltd. Patentee after: SHANGHAI JINGZE BIOLOGICAL TECHNOLOGY CO.,LTD. Patentee after: Chengdu Jingze biopharmaceutical Co.,Ltd. Address before: 230088 China (Anhui) pilot Free Trade Zone, Hefei, Anhui Province a11-1, 13 / F, block a, building J1, phase II, innovation industrial park, No. 2800, innovation Avenue, high tech Zone, Hefei Patentee before: Jingze biomedical (Hefei) Co.,Ltd. Patentee before: SHANGHAI JINGZE BIOLOGICAL TECHNOLOGY CO.,LTD. Patentee before: Chengdu Jingze biopharmaceutical Co.,Ltd. |